Learn about our progress developing antibody-based therapies for SARS-CoV-2 in this presentation from Dr. Miranda Byrne-Steele, featured at Beckman Coulter Life Sciences’ COVID-19 Research Symposium.
COVID-19 is very much a part of our lives today. Without herd immunity, we will need stopgap treatments to help patients fight SARS-CoV-2. We are actively researching and developing promising antibody-based therapies for pandemic mitigation. In this presentation, learn how research into vaccines to block the transmission of malaria informs our work, as well as how 7-chain repertoire analysis reveals class-switched clusters specific to epitopes of SARS-CoV-2. Finally, understand how COVID-specific responses of the B cell subset helps inform development of passive immunotherapy treatments.
